Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance and PK of [14C]INCB099280
NCT06309394Phase 1Completed
- Sponsor
- Incyte
- Start
- May 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of incb099280 in solid tumor (advanced stage), sponsored by Incyte. Primary endpoint: Total Recovery (Urine + Feces) of the Administered Radioactivity. Started May 2024; status: completed.
02
Drugs
incb099280
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT06309394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06309394.